PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset

Active filters

  • Chemical substance: Interferon beta
Presentation Product Chemical substance Chapter Items dispensed
Avonex 30microgram inj vials
0802040M0BDAAAE
Avonex Interferon beta Malignant Disease and Immunosuppression No data available
Avonex 30micrograms/0.5ml (6million units) inj pf pens
0802040M0BDACAM
Avonex Interferon beta Malignant Disease and Immunosuppression No data available
Avonex 30micrograms/0.5ml (6million units) inj pfs
0802040M0BDABAF
Avonex Interferon beta Malignant Disease and Immunosuppression No data available
Betaferon 300microgram inj vials
0802040M0BCAAAD
Betaferon Interferon beta Malignant Disease and Immunosuppression No data available
Extavia 300microgram inj vials
0802040M0BEAAAD
Extavia Interferon beta Malignant Disease and Immunosuppression No data available
Generic Rebif initiation pack
0802040M0AAALAL
Interferon B Interferon beta Malignant Disease and Immunosuppression No data available
Interferon beta-1a 12 million units/0.5ml inj 1.5ml cart
0802040M0AAAKAK
Interferon B Interferon beta Malignant Disease and Immunosuppression No data available
Interferon beta-1a 12million units/0.5ml inj pf dispos dev
0802040M0AAANAN
Interferon B Interferon beta Malignant Disease and Immunosuppression No data available
Interferon beta-1a 12million units/0.5ml inj pfs
0802040M0AAAGAG
Interferon B Interferon beta Malignant Disease and Immunosuppression No data available
Interferon beta-1a 30microgram inj vials
0802040M0AAAEAE
Interferon B Interferon beta Malignant Disease and Immunosuppression No data available
Interferon beta-1a 6million units/0.5ml inj 1.5ml cartridges
0802040M0AAAJAJ
Interferon B Interferon beta Malignant Disease and Immunosuppression No data available
Interferon beta-1a 6million units/0.5ml inj pf dispos dev
0802040M0AAAMAM
Interferon B Interferon beta Malignant Disease and Immunosuppression No data available
Interferon beta-1a 6million units/0.5ml inj pfs
0802040M0AAAFAF
Interferon B Interferon beta Malignant Disease and Immunosuppression No data available
Interferon beta-1a 6mu/0.5ml & 2.4mu/0.2ml inj pf dev
0802040M0AAAQAQ
Interferon B Interferon beta Malignant Disease and Immunosuppression No data available
Interferon beta-1a 6mu/0.5ml & 2.4mu/0.2ml inj pfs
0802040M0AAAIAI
Interferon B Interferon beta Malignant Disease and Immunosuppression No data available
Interferon beta-1b 300microgram inj vials
0802040M0AAADAD
Interferon B Interferon beta Malignant Disease and Immunosuppression No data available
Rebif 22microg/0.5ml (6million units) inj pre-filled pens
0802040M0BBAJAM
Rebif Interferon beta Malignant Disease and Immunosuppression No data available
Rebif 22microg/0.5ml inj and Rebif 8.8microg/0.2ml inj
0802040M0BBALAQ
Rebif Interferon beta Malignant Disease and Immunosuppression No data available
Rebif 22microg/0.5ml inj and Rebif 8.8microg/0.2ml inj pfs
0802040M0BBAFAI
Rebif Interferon beta Malignant Disease and Immunosuppression No data available
Rebif 22micrograms/0.5ml (6million units) inj 1.5ml cart
0802040M0BBAGAJ
Rebif Interferon beta Malignant Disease and Immunosuppression No data available
Rebif 22micrograms/0.5ml (6million units) inj pfs
0802040M0BBADAF
Rebif Interferon beta Malignant Disease and Immunosuppression No data available
Rebif 44micrograms/0.5ml (12million units) inj 1.5ml cart
0802040M0BBAHAK
Rebif Interferon beta Malignant Disease and Immunosuppression No data available
Rebif 44micrograms/0.5ml (12million units) inj pf pens
0802040M0BBAKAN
Rebif Interferon beta Malignant Disease and Immunosuppression No data available
Rebif 44micrograms/0.5ml (12million units) inj pfs
0802040M0BBAEAG
Rebif Interferon beta Malignant Disease and Immunosuppression No data available
Rebif 8.8microg/0.1ml with 22microg/0.25ml initiation pack
0802040M0BBAIAL
Rebif Interferon beta Malignant Disease and Immunosuppression No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.